References
http://nobelprize.org/nobel_prizes/medicine/laureates/1908/ehrlich-lecture.html
Nordberg A. Amyloid plaque imaging in vivo: current achievement and future prospects. Eur J Nucl Med Mol Imaging 2008;35(Suppl 1):S46–50.
Thompson PW, Ye L, Morgenstern JL, Sue L, Beach TG, Judd DJ, et al. Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies. J Neurochem 2009. doi:10.1111/j.1471–4159.2009.05996.x.
Ikonomovic MD, Klunk WE, Abrahamson EE, Mathis CA, Price JC, Tsopelas ND, et al. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain 2008;131(Pt 6):1630–45.
Svedberg MM, Hall H, Hellström-Lindahl E, Estrada S, Guan Z, Nordberg A, et al. [(11)C]PIB-amyloid binding and levels of Abeta40 and Abeta42 in postmortem brain tissue from Alzheimer patients. Neurochem Int 2008. doi:10.1016/j.neuint.2008.12.016.
McNamee RL, Yee SH, Price JC, Klunk WE, Rosario B, Weissfeld L, et al. Consideration of optimal time window for Pittsburgh compound B PET summed uptake measurements. J Nucl Med 2009;50(3):348–55.
Raniga P, Bourgeat P, Fripp J, Acosta O, Villemagne VL, Rowe C, et al. Automated (11)C-PiB standardized uptake value ratio. Acad Radiol 2008;15(11):1376–89.
Razifar P, Engler H, Ringheim A, Estrada S, Wall A, Långström B. An automated method for delineating a reference region using masked volumewise principal-component analysis in 11C-PIB PET. J Nucl Med Technol 2009;37(1):38–44.
Mikhno A, Devanand D, Pelton G, Cuasay K, Gunn R, Upton N, et al. Voxel-based analysis of 11C-PIB scans for diagnosing Alzheimer's disease. J Nucl Med 2008;49(8):1262–9.
Mourik JE, Lubberink M, Schuitemaker A, Tolboom N, van Berckel BN, Lammertsma AA, et al. Image-derived input functions for PET brain studies. Eur J Nucl Med Mol Imaging 2009;36(3):463–71.
Yaqub M, Tolboom N, Boellaard R, van Berckel BN, van Tilburg EW, Luurtsema G, et al. Simplified parametric methods for [11C]PIB studies. Neuroimage 2008;42(1):76–86.
O'Keefe GJ, Saunder TH, Ng S, Ackerman U, Tochon-Danguy HJ, Chan JG, et al. Radiation dosimetry of {beta}-amyloid tracers 11C-PiB and 18F-BAY94–9172. J Nucl Med 2009;50(2):309–15.
Li Y, Rinne JO, Mosconi L, Pirraglia E, Rusinek H, DeSanti S, et al. Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease. Eur J Nucl Med Mol Imaging 2008;35(12):2169–81.
Rabinovici GD, Jagust WJ, Furst AJ, Ogar JM, Racine CA, Mormino EC, et al. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol 2008;64(4):388–401.
Sojkova J, Beason-Held L, Zhou Y, An Y, Kraut MA, Ye W, et al. Longitudinal cerebral blood flow and amyloid deposition: an emerging pattern? J Nucl Med 2008;49(9):1465–71.
Okello A, Edison P, Archer HA, Turkheimer FE, Kennedy J, Bullock R, et al. Microglial activation and amyloid deposition in mild cognitive impairment: a PET study. Neurology 2009;72(1):56–62.
Wiley CA, Lopresti BJ, Venneti S, Price J, Klunk WE, DeKosky ST, et al. Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease. Arch Neurol 2009;66(1):60–7.
Acknowledgments
The author is grateful to Ms. Catherine Wrenn for her editorial support.
Author information
Authors and Affiliations
Corresponding author
Additional information
“Focus on…” abridgements aim to highlight papers published within the past year and draw extensively on the texts and summaries of the articles referenced. Less recent citations are also included when deemed useful to provide background information on the topic reviewed.
Rights and permissions
About this article
Cite this article
Lucignani, G. Amyloid imaging with PET: methodological issues and correlative studies. Eur J Nucl Med Mol Imaging 36, 1009–1014 (2009). https://doi.org/10.1007/s00259-009-1124-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-009-1124-y